Clinical outcome and correlates of coronary microvascular obstruction in latecomers after acute myocardial infarction

International Journal of Cardiology

Volumn 236, Issue , 2017, Pages 30-35

  Montone, Rocco A ^a,b   Niccoli, Giampaolo ^a   Minelli, Silvia ^a   Fracassi, Francesco ^a   Vetrugno, Vincenzo ^a   Aurigemma, Cristina ^a   Burzotta, Francesco ^a   Porto, Italo ^a   Trani, Carlo ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY MICROVASCULAR OBSTRUCTION; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART VENTRICLE REMODELING; HIGH RISK POPULATION; HOSPITAL READMISSION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ADVERSE DRUG REACTION; COMPLICATION; CORONARY ARTERY OCCLUSION; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; EPIDEMIOLOGY; ITALY; MICROVASCULATURE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

AGED; CORONARY OCCLUSION; CORONARY VESSELS; FEMALE; HEART FAILURE; HUMANS; ITALY; LONG TERM ADVERSE EFFECTS; MALE; MICROVESSELS; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; SEVERITY OF ILLNESS INDEX; ST ELEVATION MYOCARDIAL INFARCTION; SURVIVAL ANALYSIS; VENTRICULAR REMODELING;

EID: 85012871557     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2017.02.023     Document Type: Article

References (41)

1. [1] Steg, P.G., James, S.K., Atar, D., Badano, L.P., Blömstrom-Lundqvist, C., Borger, M.A., Di Mario, C., Dickstein, K., Ducrocq, G., Fernandez-Aviles, F., Gershlick, A.H., Giannuzzi, P., Halvorsen, S., Huber, K., Juni, P., Kastrati, A., Knuuti, J., Lenzen, M.J., Mahaffey, K.W., Valgimigli, M., van't Hof, A., Widimsky, P., Zahger, D., ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur. Heart J. 33 (2012), 2569–2619.
2. [2] Levine, G.N., Bates, E.R., Blankenship, J.C., Bailey, S.R., Bittl, J.A., Cercek, B., Chambers, C.E., Ellis, S.G., Guyton, R.A., Hollenberg, S.M., Khot, U.N., Lange, R.A., Mauri, L., Mehran, R., Moussa, I.D., Mukherjee, D., Ting, H.H., O'Gara, P.T., Kushner, F.G., Ascheim, D.D., Brindis, R.G., Casey, D.E. Jr., Chung, M.K., de Lemos, J.A., Diercks, D.B., Fang, J.C., Franklin, B.A., Granger, C.B., Krumholz, H.M., Linderbaum, J.A., Morrow, D.A., Newby, L.K., Ornato, J.P., Ou, N., Radford, M.J., Tamis-Holland, J.E., Tommaso, C.L., Tracy, C.M., Woo, Y.J., Zhao, D.X., 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. J. Am. Coll. Cardiol. 67 (2016), 1235–1250.
3. [3] Schömig, A., Ndrepepa, G., Kastrati, A., Late myocardial salvage: time to recognize its reality in the reperfusion therapy of acute myocardial infarction. Eur. Heart J. 27 (2006), 1900–1907.
4. [4] De Luca, G., Suryapranata, H., Ottervanger, J.P., Antman, E.M., Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 109 (2004), 1223–1225.
5. [5] Hochman, J.S., Lamas, G.A., Buller, C.E., Dzavik, V., Reynolds, H.R., Abramsky, S.J., Forman, S., Ruzyllo, W., Maggioni, A.P., White, H., Sadowski, Z., Carvalho, A.C., Rankin, J.M., Renkin, J.P., Steg, P.G., Mascette, A.M., Sopko, G., Pfisterer, M.E., Leor, J., Fridrich, V., Mark, D.B., Knatterud, G.L., Investigators, Occluded Artery Trial, Coronary intervention for persistent occlusion after myocardial infarction. N. Engl. J. Med. 355 (2006), 2395–2407.
6. [6] Schömig, A., Mehilli, J., Antoniucci, D., Ndrepepa, G., Markwardt, C., Di Pede, F., Nekolla, S.G., Schlotterbeck, K., Schühlen, H., Pache, J., Seyfarth, M., Martinoff, S., Benzer, W., Schmitt, C., Dirschinger, J., Schwaiger, M., Kastrati, A., Beyond 12 hours Reperfusion AlternatiVe Evaluation (BRAVE-2) Trial Investigators, Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA 293 (2005), 2865–2872.
7. [7] Busk, M., Kaltoft, A., Nielsen, S.S., Bøttcher, M., Rehling, M., Thuesen, L., Bøtker, H.E., Lassen, J.F., Christiansen, E.H., Krusell, L.R., Andersen, H.R., Nielsen, T.T., Kristensen, S.D., Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for < 12 h vs. 12–72 h. Eur. Heart J. 30 (2009), 1322–1330.
8. [8] Kastrati, A., Mehilli, J., Nekolla, S., Bollwein, H., Martinoff, S., Pache, J., Schühlen, H., Seyfarth, M., Gawaz, M., Neumann, F.J., Dirschinger, J., Schwaiger, M., Schömig, A., STOPAMI-3 Study Investigators, A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy. J. Am. Coll. Cardiol. 43 (2004), 734–741.
9. [9] Koeth, O., Zahn, R., Gitt, A.K., Bauer, T., Juenger, C., Senges, J., Zeymer, U., Maximal Individual Therapy in Acute Myocardial Infarction Plus Study Group, Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction plus Registry). Am. J. Cardiol. 104 (2009), 1074–1077.
10. [10] Cohen, M., Gensini, G.F., Maritz, F., Gurfinkel, E.P., Huber, K., Timerman, A., Krzeminska-Pakula, M., Santopinto, J., Hecquet, C., Vittori, L., TETAMI Investigators, Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI Registry and Randomized Trial. Circulation, 108, 2003 (III-14-21).
11. [11] Niccoli, G., Scalone, G., Lerman, A., Crea, F., Coronary microvascular obstruction in acute myocardial infarction. Eur. Heart J. 37:13 (2016), 1024–1033.
12. [12] Sabia, P.J., Powers, E.R., Ragosta, M., Sarembock, I.J., Burwell, L.R., Kaul, S., An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N. Engl. J. Med. 327 (1992), 1825–1831.
13. [13] Bax, M., de Winter, R.J., Schotborgh, C.E., Koch, K.T., Meuwissen, M., Voskuil, M., Adams, R., Mulder, K.J., Tijssen, J.G., Piek, J.J., Short- and long-term recovery of left ventricular function predicted at the time of primary percutaneous coronary intervention in anterior myocardial infarction. J. Am. Coll. Cardiol. 43 (2004), 534–541.
14. [14] Ndrepepa, G., Tiroch, K., Fusaro, M., Keta, D., Seyfarth, M., Byrne, R.A., Pache, J., Alger, P., Mehilli, J., Schomig, A., Kastrati, A., 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 55 (2010), 2383–2389.
15. [15] Araszkiewicz, A., Grajek, S., Lesiak, M., Prech, M., Pyda, M., Janus, M., Cieslinski, A., Effect of impaired myocardial reperfusion on left ventricular remodeling in patients with anterior wall acute myocardial infarction treated with primary coronary intervention. J. Cardiol. 98 (2006), 725–728.
16. [16] Henriques, J.P., Zijlstra, F., Van't Hof, A.W., de Boer, M.J., Dambrink, J.H., Gosselink, M., Hoorntje, J.C., Suryapranata, H., Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 107 (2003), 2115–2119.
17. [17] TIMI Study Group, The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. TIMI Study Group. N. Engl. J. Med. 312 (1985), 932–936.
18. [18] Gibson, C.M., Cannon, C.P., Daley, W.L., Dodge, J.T. Jr., Alexander, B. Jr., Marble, S.J., McCabe, C.H., Raymond, L., Fortin, T., Poole, W.K., Braunwald, E., TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93 (1996), 879–888.
19. [19] van't Hof, A.W., Liem, A., Suryapranata, H., Hoorntje, J.C., de Boer, M.J., Zijlstra, F., Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 97 (1998), 2302–2306.
20. [20] Gibson, C.M., de Lemos, J.A., Murphy, S.A., Marble, S.J., McCabe, C.H., Cannon, C.P., Antman, E.M., Braunwald, E., TIMI Study Group, Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 103 (2001), 2550–2554.
21. [21] Niccoli, G., Lanza, G.A., Shaw, S., Romagnoli, E., Gioia, D., Burzotta, F., Trani, C., Mazzari, M.A., Mongiardo, R., De Vita, M., Rebuzzi, A.G., Lüscher, T.F., Crea, F., Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization. Eur. Heart J. 27 (2006), 1793–1798.
22. [22] Gibson, C.M., Murphy, S.A., Morrow, D.A., Aroesty, J.M., Gibbons, R.J., Gourlay, S.G., Barron, H.V., Giugliano, R.P., Antman, E.M., Braunwald, E., Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. Am. Heart J. 148 (2004), 336–340.
23. [23] Rentrop, K.P., Cohen, M., Blanke, H., Phillips, R.A., Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J. Am. Coll. Cardiol. 5 (1985), 587–592.
24. [24] Lancellotti, P., Moura, L., Pierard, L.A., Agricola, E., Popescu, B.A., Tribouilloy, C., Hagendorff, A., Monin, J.L., Badano, L., Zamorano, J.L., European Association of Echocardiography, European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur. J. Echocardiogr. 11 (2010), 307–332.
25. [25] White, H.D., Norris, R.M., Brown, M.A., Brandt, P.W., Whitlock, R.M., Wild, C.J., Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76 (1987), 44–51.
26. [26] Hung, C.L., Verma, A., Uno, H., Shin, S.H., Bourgoun, M., Hassanein, A.H., McMurray, J.J., Velazquez, E.J., Kober, L., Pfeffer, M.A., Solomon, S.D., VALIANT investigators, Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction. J. Am. Coll. Cardiol. 56:22 (2010), 1812–1822.
27. [27] Nagueh, S.F., Smiseth, O.A., Appleton, C.P., Byrd, B.F. 3rd, Dokainish, H., Edvardsen, T., Flachskampf, F.A., Gillebert, T.C., Klein, A.L., Lancellotti, P., Marino, P., Oh, J.K., Popescu, B.A., Waggoner, A.D., Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 29:4 (2016), 277–314.
28. [28] Niccoli, G., Rigattieri, S., De Vita, M.R., Valgimigli, M., Corvo, P., Fabbiocchi, F., Romagnoli, E., De Caterina, A.R., La Torre, G., Lo Schiavo, P., Tarantino, F., Ferrari, R., Tomai, F., Olivares, P., Cosentino, N., D'Amario, D., Leone, A.M., Porto, I., Burzotta, F., Trani, C., Crea, F., Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction). JACC Cardiovasc. Interv. 6 (2013), 580–589.
29. [29] Niccoli, G., Cosentino, N., Spaziani, C., Fracassi, F., Tarantini, G., Crea, F., No-reflow: incidence and detection in the cath-lab. Curr. Pharm. Des. 19 (2013), 4564–4575.
30. [30] Kloner, R.A., Ganote, C.E., Jennings, R.B., The ‘no reflow’ phenomenon after temporary occlusion in the dog. J. Clin. Invest. 54 (1974), 1496–1508.
31. [31] Herrmann, J., Lerman, A., The endothelium: dysfunction and beyond. J. Nucl. Cardiol. 8 (2001), 197–206.
32. [32] Iwakura, K., Ito, H., Kawano, S., Shintani, Y., Yamamoto, K., Kato, A., Ikushima, M., Tanaka, K., Kitakaze, M., Hori, M., Higashino, Y., Fujii, K., Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J. Am. Coll. Cardiol. 38 (2001 Aug), 472–477.
33. [33] Nakagawa, Y., Ito, H., Kitakaze, M., Kusuoka, H., Hori, M., Kuzuya, T., Higashino, Y., Fujii, K., Minamino, T., Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: retrospective clinical evidence of ‘preconditioning’. J. Am. Coll. Cardiol. 25 (1995), 1076–1083.
34. [34] Ottani, F., Galvani, M., Ferrini, D., Sorbello, F., Limonetti, P., Pantoli, D., Rusticali, F., Prodromal angina limits infarct size. A role for ischemic preconditioning. Circulation 91 (1995), 291–297.
35. [35] Kloner, R.A., Shook, T., Przyklenk, K., Davis, V.G., Junio, L., Matthews, R.V., Burstein, S., Gibson, M., Poole, W.K., Cannon CP for the TIMI 4 investigators. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning?. Circulation 91 (1995), 37–45.
36. [36] Andreotti, F., Pasceri, V., Hackett, D.R., Davies, G.J., Haider, A.W., Maseri, A., Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N. Engl. J. Med. 334 (1996), 7–12.
37. [37] Karila-Cohen, D., Czitrom, D., Brochet, E., Faraggi, M., Seknadji, P., Himbert, D., Juliard, J.M., Assayag, P., Steg, P.G., Decreased no-reflow in patients with anterior myocardial infarction and pre-infarction angina. Eur. Heart J. 20 (1999 Dec), 1724–1730.
38. [38] Desch, S., Stiermaier, T., de Waha, S., Lurz, P., Gutberlet, M., Sandri, M., Mangner, N., Boudriot, E., Woinke, M., Erbs, S., Schuler, G., Fuernau, G., Eitel, I., Thiele, H., Thrombus aspiration in patients with ST-segment elevation myocardial infarction presenting late after symptom onset. JACC Cardiovasc. Interv. 9:2 (2016), 113–122.
39. [39] Galiuto, L., Gabrielli, F.A., Lombardo, A., La Torre, G., Scara`, A., Rebuzzi, A.G., Crea, F., Reversible microvascular dysfunction coupled with persistent myocardial dysfunction: implications for post-infarct left ventricular remodelling. Heart 93 (2007), 565–571.
40. [40] Steg, P.G., Kerner, A., Mancini, G.B., Reynolds, H.R., Carvalho, A.C., Fridrich, V., White, H.D., Forman, S.A., Lamas, G.A., Hochman, J.S., Buller, C.E., Investigators, O.A.T., Impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: a report from the randomized occluded artery trial. Circulation 121 (2010), 2724–2730.
41. [41] Niccoli, G., Fracassi, F., Cosentino, N., Falcioni, E., Roberto, M., De Luca, G., Leone, A.M., Burzotta, F., Porto, I., Trani, C., Severino, A., Crea, F., No-reflow reversibility: a study based on serial assessment of multiple biomarkers. J. Cardiovasc. Transl. Res. 6 (2013), 798–807.